Literature DB >> 16651530

Requirement of Rac1 in the development of cardiac hypertrophy.

Minoru Satoh1, Hisakazu Ogita, Kyosuke Takeshita, Yasushi Mukai, David J Kwiatkowski, James K Liao.   

Abstract

The development of cardiac hypertrophy is mediated, in part, by increase in NADPH oxidase activity and myocardial oxidative stress. The Rho GTPase, Rac, regulates NADPH oxidase activity through interaction with gp91(phox) and p67(phox) (in which "phox" is phagocyte oxidase). However, it is not known which Rac isoform mediates this effect in the heart. Here we show that Rac1 is critical for generating oxidative stress and producing cardiac hypertrophy in the adult heart. The Rac1 gene was temporally and specifically deleted in adult mouse cardiomyocytes (c-Rac1(-/-)). Compared with wild-type or Rac1 heterozygous mice, the hearts of c-Rac1(-/-) mice showed decreased gp91(phox) and p67(phox) interaction, NADPH oxidase activity, and myocardial oxidative stress in response to angiotensin II (400 ng/kg per day for 2 weeks) stimulation. This result correlated with decreased myocardial hypertrophy. These results indicate that Rac1 is critical for the hypertrophic response in the heart and suggest that therapies which target myocardial Rac1 may be beneficial in the treatment of cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651530      PMCID: PMC1455410          DOI: 10.1073/pnas.0510444103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.

Authors:  D S Sohal; M Nghiem; M A Crackower; S A Witt; T R Kimball; K M Tymitz; J M Penninger; J D Molkentin
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

2.  Rac1 is required for the formation of three germ layers during gastrulation.

Authors:  K Sugihara; N Nakatsuji; K Nakamura; K Nakao; R Hashimoto; H Otani; H Sakagami; H Kondo; S Nozawa; A Aiba; M Katsuki
Journal:  Oncogene       Date:  1998-12-31       Impact factor: 9.867

3.  Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt.

Authors:  Yasushi Mukai; Yoshiyuki Rikitake; Ichiro Shiojima; Sebastian Wolfrum; Minoru Satoh; Kyosuke Takeshita; Yukio Hiroi; Salvatore Salomone; Hyung-Hwan Kim; Laura E Benjamin; Kenneth Walsh; James K Liao
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

4.  Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

Authors:  Jennifer K Bendall; Alison C Cave; Christophe Heymes; Nicholas Gall; Ajay M Shah
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 5.  The Rho GTPases in macrophage motility and chemotaxis.

Authors:  G E Jones; W E Allen; A J Ridley
Journal:  Cell Adhes Commun       Date:  1998

6.  Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice.

Authors:  Minoru Satoh; Naoki Kashihara; Yasushi Yamasaki; Keisuke Maruyama; Kazunori Okamoto; Youhei Maeshima; Hitoshi Sugiyama; Takeshi Sugaya; Kazuo Murakami; Hirofumi Makino
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

7.  Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.

Authors:  M Takemoto; K Node; H Nakagami; Y Liao; M Grimm; Y Takemoto; M Kitakaze; J K Liao
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

8.  Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1.

Authors:  M A Sussman; S Welch; A Walker; R Klevitsky; T E Hewett; R L Price; E Schaefer; K Yager
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

9.  Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.

Authors:  Lian Zuo; Masuko Ushio-Fukai; Satoshi Ikeda; Lula Hilenski; Nikolay Patrushev; R Wayne Alexander
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

10.  Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.

Authors:  Yoshiyuki Rikitake; Naotsugu Oyama; Chao-Yung C Wang; Kensuke Noma; Minoru Satoh; Hyung-Hwan Kim; James K Liao
Journal:  Circulation       Date:  2005-10-31       Impact factor: 29.690

View more
  108 in total

1.  NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

Authors:  Min Zhang; Alison C Brewer; Katrin Schröder; Celio X C Santos; David J Grieve; Minshu Wang; Narayana Anilkumar; Bin Yu; Xuebin Dong; Simon J Walker; Ralf P Brandes; Ajay M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.

Authors:  Balachandar Venkatesan; Anthony J Valente; Sumanth D Prabhu; Prakashsrinivasan Shanmugam; Patrice Delafontaine; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2010-06-09       Impact factor: 5.000

Review 3.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

4.  Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.

Authors:  Jie Yan; Martin E Young; Lei Cui; Gary D Lopaschuk; Ronglih Liao; Rong Tian
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

Review 5.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

6.  Transgenic expression of constitutively active RAC1 disrupts mouse rod morphogenesis.

Authors:  Hongman Song; Ronald A Bush; Camasamudram Vijayasarathy; Robert N Fariss; Sten Kjellstrom; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-25       Impact factor: 4.799

Review 7.  The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.

Authors:  Demetrios Moris; Michael Spartalis; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Georgios I Karaolanis; Gerasimos Tsourouflis; Diamantis I Tsilimigras; Eleni Tzatzaki; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08

8.  Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.

Authors:  Qi Zhang; Yingying Tan; Nan Zhang; Fanrong Yao
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

9.  Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR.

Authors:  Chao-Yung Wang; Hyung-Hwan Kim; Yukio Hiroi; Naoki Sawada; Salvatore Salomone; Laura E Benjamin; Kenneth Walsh; Michael A Moskowitz; James K Liao
Journal:  Sci Signal       Date:  2009-03-17       Impact factor: 8.192

Review 10.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.